Eosinophilic cystitis (EC) is a rare inflammation of the bladder that manifests as grossly thickened, edematous bladder wall with mucosal erythema and areas of plaque or ulceration on endoscopy. Histologically, EC involves transmural inflammation with a strong predominance of eosinophils in the bladder wall accompanied by fibrosis with or without muscle necrosis. 1 Presentation is generally with urinary frequency, dysuria, urgency and hematuria. 1 EC has not previously been reported in relation to hematopoietic stem cell transplantation (HST). Here, we describe an EC case following allogenic cord blood transplantation.
A 45-year-old woman was admitted to our hospital due to relapsed acute myelomonocytic leukemia (World Health Organization classification). The patient had no specific symptoms on admission, and she had neither contributory family history nor any past history. On admission, there were no notable findings regarding lymph nodes, liver or spleen size. Laboratory data demonstrated marked anemia with hemoglobin of 4.5 g per 100 ml, elevated leukocyte count of 29.5 Â 10 9 per l with blast cells in the peripheral blood (65%) and a decreased platelet count of 4.6 Â l0 4 per ml. Initially, the patient was treated with a combination of idarubicin and ara-C as induction chemotherapy, but this regimen was ineffective. Next the patient received highdose ara-C, which also failed. As an HLA-identical donor was not available, we decided to utilize unrelated cord blood as a stem cell source for transplantation. She was treated with a conditioning regimen consisting of TBI (4 Gy divided into two fractions on day À2), fludarabine 25 mg/m 2 , every 24 h on days À7 to À3 and cytarabine 2 g/m 2 every 12 h on days À6 to À3 (total dose, 16 g/m 2 ). On day 0, she received one unrelated cord blood unit from a male donor whose HLA antigens were serologically and genotypically fully matched. The number of nucleated unrelated cord blood cells before cryopreservation was 1.65 Â 10 7 per kg recipient weight and for CD34-positive cells, 1.11 Â 10 5 per kg. GVHD prophylaxis consisted of tacrolimus 0.03 mg/kg from day À1. She reached an ANC 40.5 Â 10 9 per l on day 24 and untransfused platelets of 450 Â 10 9 per l on day 39. Full donor chimerism was confirmed by analysis of short tandem repeat microsatellite markers on day 23. There was no evidence of acute GVHD at this point. From day 28, she began to complain of a feeling of incomplete emptying of the bladder and pain on urination. Urinalysis showed proteinuria and microscopic hematuria. Urine cultures were negative. Cystoscopic examination performed on day 30 demonstrated spotty edematous regions with bleeding and petechial hemorrhagic lesions. Biopsy showed edema, interstitial fibrosis, vascular dilatation and massive infiltration with eosinophils and lymphocytes, diagnosed as EC (Figure 1 ). Epithelial mucosa of the specimen showed desquamation. Although, polyomavirus BK was not studied, PCR demonstrated more than 10 5 copies of adenovirus, which led us to treat the patient initially with adenosine arabinoside. Although adenosine arabinoside did not improve the patient's clinical symptoms, it decreased the copy numbers of adenovirus by more than 4 log. To further decrease the viral load, we decided to administer 40 mg prednisolone, which dramatically improved the patient's symptoms. On day 66, repeat cystoscopic examination demonstrated residual edema, interstitial fibrosis, vascular dilatation and infiltration by lymphocytes but the eosinophils were totally diminished. Administration of 20 mg prednisolone was continued and on day 101 after transplantation, the patient was discharged from hospital with fully recovered hematological parameters and there was no sign of either GVHD or cystitis.
Hemorrhagic cystitis (HC) is a major cause of morbidity after HST. HC is a syndrome that might be defined clinically as macroscopic hematuria or sustained microhematuria for more than 14 days with clinical signs of cystitis de novo at least 10 days after HST, not with a tendency for generalized bleeding or bacteriuria HC. 2 EC is an inflammatory bladder disease of unknown etiology that is diagnosed only on histological examination. 1 Although EC can cause hematuria and seems to share some features with HC following HST, EC has not been reported in relation to HC following HST. This might be due to the difficulty in obtaining biopsy material for HC following HST, as most cases of HC following HST occur while thrombocytopenia is also present. One possible explanation for EC in our patient is that we were simply observing the pathological side of an ordinary episode of HC following HST, as our patient had adenovirus infection at the onset of EC.
Eosinophils are inflammatory cells that play an important role in defending the host against parasitic pathogens. On activation, eosinophils release cationic granule proteins that exert cytotoxic effects on epithelial cells in vivo. 3 Daneshpouy et al. 4 performed systematic duodenal biopsies immediately after gastric symptoms occurred and found that eosinophils were present only when there were histologic signs of GVHD; eosinophil presence correlated with GVHD severity, and they concluded that tissue eosinophil concentrations are a marker of acute inflammatory reaction during GVHD flare-ups. There are similar reports by Basara et al. 5 in BM, based on a systematic prospective study of BM smears and biopsies. Therefore, although the urinary bladder is not a main target organ for GVHD, there is the possibility that EC occurring in our patient was a form of acute GVHD. However, as epithelial mucosa, the main target of GVHD, had been desquamated from the specimen, the relation between GVHD and EC is difficult to clarify.
The exact etiology of EC is unknown; however, most investigators postulate an immunological etiology. Agents such as CY and thiotepa have been linked with EC. However, removal of the causative factor results in a good cure rate. Although EC in our case may have been drug-induced, this possibility seems less likely to us because we discontinued all drugs except tacrolimus, which strongly suppresses eosinophilia. Although the patient lacked typical symptoms of GVHD such as high fever and rash, another explanation for eosinophilia is drug-induced hypersensitivity caused by human herpesvirus 6, which is significantly related to cord blood transplantation. 6, 7 The incidence and clinical significance of EC following HST, in this case, remain unclear. This may be due to the restricted use of diagnostic histology of the bladder after HST, and accumulation of further data is required to resolve this issue. 
